APA (7th ed.) Citation

X, Y., L, X., C, B., D, D., L, C., X, Y., . . . K, S. (2018). Lactoferrin-modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS/MS-based drug biodistribution, pharmacodynamics, and neuroprotective effects. Dove Medical Press.

Chicago Style (17th ed.) Citation

X, Yan, Xu L, Bi C, Duan D, Chu L, Yu X, Wu Z, Wang A, and Sun K. Lactoferrin-modified Rotigotine Nanoparticles for Enhanced Nose-to-brain Delivery: LESA-MS/MS-based Drug Biodistribution, Pharmacodynamics, and Neuroprotective Effects. Dove Medical Press, 2018.

MLA (8th ed.) Citation

X, Yan, et al. Lactoferrin-modified Rotigotine Nanoparticles for Enhanced Nose-to-brain Delivery: LESA-MS/MS-based Drug Biodistribution, Pharmacodynamics, and Neuroprotective Effects. Dove Medical Press, 2018.